Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Ukraine restricts Telegram for officials over national security concerns due to its misuse for cyber attacks.
Stocks surge post-Fed rate cut; biotech sector shines. Industry experts discuss market trends and potential bull market drivers.
Citi resumes Eli Lilly coverage with Buy rating, driven by optimistic tirzepatide forecasts for diabetes and obesity treatments.
DASI Simulations' AI gains FDA clearance, aiding TAVR planning and boosting cardiology's role in healthcare AI.
Moderna shares dip as R&D spending reduces, focusing on FDA approval for 10 key products including RSV and cancer treatments.
Fovus uses AI to simplify HPC, cutting costs and boosting speed for drug discovery in pharma and biotech sectors.
Singapore bans cryptocurrency in casinos citing money laundering concerns, aligning with global trends in gambling regulations.
Medera aims for Nasdaq listing via SPAC to boost gene therapies, spotlighting rare biotech SPACs in 2024.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.